Skip to content

Effects of sitagliptin and vildagliptin on glucose fluctuations in patients with type 2 diabetes -prospective open-label controlled study-

Effects of sitagliptin and vildagliptin on glucose fluctuations in patients with type 2 diabetes -prospective open-label controlled study- - Effects of sitagliptin and vildagliptin on glucose fluctuations in patients with type 2 diabetes

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000005627
Enrollment
40
Registered
2011-06-01
Start date
2011-06-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

type 2 diabetes mellitus

Interventions

vildagliptin sitagliptin

Sponsors

Department of Medicine II, Hokkaido University Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1) patients with type 2 diabetes using sitagliptin (50mg, once daily) or vildagliptin(50mg, twice daily) for more than 3 months 2) HbA1c 5.8-7.9% (JDS), HbA1c 6.2-8.3%(NGSP) 3) written informed consent

Exclusion criteria

Exclusion criteria: 1) patients who received insulin injection therapy 2) severe hepatic dysfunction, renal dysfunction, heart failure 3) history of anaphylaxis of Sitagliptin or Vildagliptin, 4) pregnancy and lactation 5) patients who are inadequate to enter this study due to the other reasons by physician's judgments

Design outcomes

Primary

MeasureTime frame
To evaluate changes in MAGE; mean amplitude of glycemic excursions before and after switching from sitagliptin to vildagliptin, and vice versa

Secondary

MeasureTime frame
1) M-value 2) fasting plasma glucose, HbA1c, glycoalbumin 3) beta cell function 4) changes in body weight, Body Mass Index, abdominal girth, blood pressure 5) several biomarkers

Countries

Japan

Contacts

Public ContactHideaki Miyoshi

Hokkaido University Hospital Department of Medicine II

hmiyoshi@med.hokudai.ac.jp011-706-5915

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026